Aldosterone and mineralocorticoid receptor signaling as determinants of cardiovascular and renal injury: an extraordinary paradigm shift

Clinical perspective—evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes

(2022) Peter Rossing   Kidney International Supplements

The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis

(2022) James M. Luther et al.   Kidney International Supplements

The renin–angiotensin system biomolecular cascade: a 2022 update of newer insights and concepts

(2022) Carlos M. Ferrario et al.   Kidney International Supplements

Epidemiology of chronic kidney disease: an update 2022

(2022) Csaba P. Kovesdy   Kidney International Supplements

Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms

(2022) Johann Bauersachs et al.   Kidney International Supplements

Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease

(2022) Toshifumi Nakamura et al.   Kidney International Supplements

The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets

(2022) Morley D. Hollenberg et al.   Kidney International Supplements

Considerations for the future: current and future treatment paradigms with mineralocorticoid receptor antagonists—unmet needs and underserved patient cohorts

(2022) Murray Epstein   Kidney International Supplements

How common is primary aldosteronism?

(2021) Gregory L. Hundemer et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

The intersection of Mineralocorticoid Receptor (MR) activation and the FGF23 – Klotho cascade. A Duopoly that promotes renal and cardiovascular injury

(2021) Murray Epstein et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Two Mineralocorticoid Receptor–Mediated Mechanisms of Pendrin Activation in Distal Nephrons

(2020) Nobuhiro Ayuzawa et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The Unrecognized Prevalence of Primary Aldosteronism

(2020) Jenifer M. Brown et al.   ANNALS OF INTERNAL MEDICINE

Evolution of the Primary Aldosteronism Syndrome: Updating the Approach

(2020) Anand Vaidya et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mineralocorticoid Receptor and Cardiovascular Disease

(2018) Mathieu Buonafine et al.   AMERICAN JOURNAL OF HYPERTENSION

Aldosterone and Mineralocorticoid Receptors—Physiology and Pathophysiology

(2017) John Funder   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice

(2017) Silvia Monticone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac FibrosisCLINICAL PERSPECTIVE

(2015) Anne-Cécile Huby et al.   CIRCULATION

Aldosterone: Role in Edematous Disorders, Hypertension, Chronic Renal Failure, and Metabolic Syndrome

(2010) R. W. Schrier et al.   Clinical Journal of the American Society of Nephrology